Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA | MicrobiomeTrials← Back to trialsNCT07415876
Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-04Est. Completion: 2027-01
Enrollment target: 50 participants Locations- Virginia Commonwealth University, Richmond, Virginia, United States
Other microbiome trials you might be interested in
Anemia, Sickle Cell
The purpose of this study is to find out whether siplizumab is safe and effective for patients with SCD undergoing an al…
New York, United StatesCompleted Dec 11, 2024
Liver Failure
The unmet medical need in solid organ transplantation is to eliminate the lifelong requirement of powerful immune suppre…
Stanford, United StatesEst. completion Aug 2031